psoriatic arthritis , anklylosing spondylitis, reactive arthritis & septic arthritis Flashcards
(144 cards)
What percentage of people with psoriasis develop Psoriatic Arthritis (PsA)?
Approximately 8% of individuals with psoriasis develop Psoriatic Arthritis (PsA).
At what age does Psoriatic Arthritis commonly begin?
Psoriatic Arthritis commonly begins between the ages of 30 and 50.
What percentage of PsA patients can have the condition without psoriasis?
10-15% of patients can have Psoriatic Arthritis without having psoriasis.
What is dactylitis, and how often does it occur in PsA patients?
Dactylitis is a distinctive sausage-like swelling affecting one or two digits, occurring in around 25% of patients.
Name some features in the history and examination of Psoriatic Arthritis.
- Personal or family history of psoriatic rash on extensor surfaces<br></br>- Joint involvement in hands and feet<br></br>- Dactylitis<br></br>- Eye disease<br></br>- Nail changes (pitting, yellowing, ridges, oncholysis)<br></br>- Enthesopathy (including Achilles tendonitis)
What are the patterns of presentation in Psoriatic Arthritis?
- Symmetrical polyarthritis (20–40%)<br></br>- Asymmetric oligoarthritis (30–55%)<br></br>- Distal interphalangeal joint disease (7–17%)<br></br>- Arthritis mutilans (5%)<br></br>- Spondylitic pattern +/– sacroiliitis (5–30%)
Describe arthritis mutilans and its characteristics.
Arthritis mutilans is an aggressive and destructive form of Psoriatic Arthritis affecting 5% of patients. It involves the reabsorption of bone, collapse of soft tissue, and telescoping of the digits.
What blood markers are raised in Psoriatic Arthritis, and what is the status of rheumatoid factor (RF)?
Raised inflammatory markers are present, but rheumatoid factor (RF) is negative in Psoriatic Arthritis.
What imaging modalities are used for investigating Psoriatic Arthritis?
- X-ray: Detects joint damage, marginal erosions, ‘whiskering’, osteolysis, and enthesitis.<br></br>- MRI: Detects early inflammatory changes.<br></br>- Ultrasound: Detects enthesitis and synovitis.
Name some non-medical management options for Psoriatic Arthritis.
Physiotherapy, occupational therapy, orthotics, and chiropodist are non-medical management options.
List some symptomatic medical treatments for Psoriatic Arthritis.
- Corticosteroids/joint injections<br></br>- Topical steroid eyedrops
What are the three categories of disease-modifying medications used for Psoriatic Arthritis?
- NSAIDs<br></br>2. csDMARDs (e.g., methotrexate, sulfasalazine, leflunomide)<br></br>3. Anti-TNF (bDMARD) in severe cases unresponsive to NSAIDs and methotrexate.
Provide examples of biologics used in the treatment of Psoriatic Arthritis.
- Secukinumab - bDMARD, anti-IL17<br></br>2. Targeted synthetic DMARDs (e.g., tofacitinib - Janus kinase inhibitor) used after the failure of csDMARDs +/– bDMARDs.
What are the first-line disease-modifying medications for Psoriatic Arthritis?
First-line disease-modifying medications include NSAIDs and csDMARDs.
What is Psoriatic Arthritis, and how is it associated with psoriasis?
Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. It ranges in severity from mild joint stiffness to complete joint destruction in arthritis mutilans.
What percentage of patients with psoriasis develop Psoriatic Arthritis, and when does it typically occur?
Psoriatic arthritis occurs in 10-20% of patients with psoriasis, usually within 10 years of developing the skin condition. It can precede skin changes and may occur at any age, most commonly in middle age.
What are the patterns of Psoriatic Arthritis, and which ones are the most common?
There are five recognized patterns: Asymmetrical oligoarthritis, Symmetrical polyarthritis, Distal interphalangeal predominant pattern, Spondylitis, and Arthritis mutilans. The most common patterns are Asymmetrical oligoarthritis and Symmetrical polyarthritis.
Describe the features of Arthritis mutilans, the most severe form of Psoriatic Arthritis.
Arthritis mutilans is the most severe form, affecting the phalanges (bones of fingers and toes). It involves osteolysis (bone destruction) around the joints, leading to progressive shortening of the digits. The telescoping digit appearance results from skin folding as the digit shortens.
How can Psoriatic Arthritis be distinguished from rheumatoid arthritis based on joint involvement?
Psoriatic arthritis tends to affect the distal interphalangeal (DIP) joints and the axial skeleton, distinguishing it from rheumatoid arthritis. Rheumatoid arthritis typically does not affect these joints.
What are some signs of Psoriatic Arthritis observed in the skin and nails?
Signs include psoriasis plaques on the skin, nail pitting, onycholysis (nail separation from the nail bed), dactylitis (inflammation of the entire finger), and enthesitis (inflammation at tendon insertion points into bone).
What is the Psoriasis Epidemiological Screening Tool (PEST), and how is it used in screening for Psoriatic Arthritis?
PEST is a screening tool involving questions about joint pain, swelling, arthritis history, and nail pitting. A high score triggers a referral to a rheumatologist, aiding in the identification of Psoriatic Arthritis in patients with psoriasis.
What are the characteristic x-ray changes seen in Psoriatic Arthritis?
X-ray changes include periostitis (inflammation of the periosteum), ankylosis (fusion of bones at the joint), osteolysis (bone destruction), and the “pencil-in-cup” appearance, associated with arthritis mutilans, featuring erosion and a cup-like appearance in the joint.
What is the classic x-ray finding in the digits associated with arthritis mutilans?
The “pencil-in-cup” appearance is the classic x-ray finding in the digits. It involves erosion of bones at the joint, creating a cup-like appearance on one side and a pointed appearance resembling a pencil on the other side. This appearance is specific to arthritis mutilans.
How is the management of Psoriatic Arthritis coordinated, and which professionals are involved?
The management involves coordination between dermatologists, rheumatologists, and a multidisciplinary team. Treatment may include NSAIDs, steroids, DMARDs (e.g., methotrexate, leflunomide, sulfasalazine), and anti-TNF medications (etanercept, infliximab, adalimumab), as well as Ustekinumab, a monoclonal antibody targeting interleukin 12 and 23.